---
title: "Nanjing Medlander Medical Technology Co.,Ltd. (688273.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688273.SH.md"
symbol: "688273.SH"
name: "Nanjing Medlander Medical Technology Co.,Ltd."
industry: "Health Care Equipment"
datetime: "2026-06-10T02:29:06.681Z"
locales:
  - [en](https://longbridge.com/en/quote/688273.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688273.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688273.SH.md)
---

# Nanjing Medlander Medical Technology Co.,Ltd. (688273.SH)

## Company Overview

Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vaginal electrodes, rectal electrodes, vaginal probes, etc. The company also provides pelvic floor muscle rehabilitation, biological feedback and stimulation systems, biological stimulation feedback device, consumables/accessories, and ultrasonic uterine involution instruments, as well as PI-ONE, a pelvic floor diagnosis and treatment system.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.medlander.com](https://www.medlander.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-09T04:30:12.000Z

**Overall: C (0.48)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 48 / 66 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -5.92% |  |
| Net Profit YoY | -18.51% |  |
| P/B Ratio | 3.32 |  |
| Dividend Ratio | 2.68% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4397539546.23 |  |
| Revenue | 413600990.85 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.30% | C |
| Profit Margin | 20.77% | A |
| Gross Margin | 66.92% | A |
| Revenue YoY | -5.92% | D |
| Net Profit YoY | -18.51% | D |
| Total Assets YoY | 6.10% | C |
| Net Assets YoY | 0.58% | C |
| Cash Flow Margin | 108.47% | C |
| OCF YoY | -5.92% | D |
| Turnover | 0.26 | D |
| Gearing Ratio | 13.86% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Nanjing Medlander Medical Technology Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-5.92%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-18.51%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.32",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.68%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4397539546.23",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "413600990.85",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.30%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "20.77%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "66.92%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-5.92%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-18.51%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "6.10%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.58%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "108.47%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-5.92%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "13.86%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 51.55 | 33/66 | 48.44 | 42.79 | 34.64 |
| PB | 3.34 | 41/66 | 3.40 | 3.05 | 2.63 |
| PS (TTM) | 10.71 | 54/66 | 10.60 | 9.36 | 8.03 |
| Dividend Yield | 2.66% | 8/66 | 2.21% | 1.67% | 1.43% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Double Medical (002901.SZ) | A | B | C | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688273.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688273.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688273.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**